Tech Company Financing Transactions
Conformation-X Therapeutics Funding Round
Conformation-X Therapeutics closed a $3.7 million funding round on 4/3/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/3/2024
Transaction Type
Venture Equity
Amount
$3,650,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its translational studies of its lead asset and facilitate the expansion of its pipeline.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
45 Dan Rd. 382
Canton, MA 02021
USA
Canton, MA 02021
USA
Phone
Website
Email Address
Overview
We are pioneering a new class of drugs that activate the immune system to recognize cancer cells as foreign invaders, helping the patients mount a natural anti-tumor response. Our therapeutics, target the tumor microenvironment of cancer cells, recruiting and amplifying the patient's own immune system to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ali Munawar
Browse more venture capital transactions:
Prev: 4/3/2024: Iceberg Data Lab venture capital transaction
Next: 4/3/2024: Aiorde venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs